Arbitrator Decisions

Claimant did not provide sufficient evidence to establish that the HCV Infected Person received a blood transfusion in Canada during the Class Period.

 

 

 

Negative traceback

Loss of Services

 

Non-prescription intravenous drug use

 

 

 

 

FOR FURTHER DETAILS, VISIT HEPC8690.CA

The terms of the HCV Late Claims Benefit Plan shall govern the claims process and can be found here

 

FOR FURTHER DETAILS, VISIT HEPC8690.CA